Topical Bimatoprost in the Treatment of Migraine
NCT03419715
·
clinicaltrials.gov ↗
PHASE2
Phase
UNKNOWN
Status
70
Enrollment
INDUSTRY
Sponsor class
Conditions
Migraine Disorders
Headache Disorders
Interventions
DRUG:
Bimatoprost Topical Solution
DRUG:
Control
Sponsor
Manistee Partners